Hypocretin‐1 (orexin‐A) concentrations in cerebrospinal fluid are low in patients with Guillain–Barré syndrome
Open Access
- 6 June 2002
- journal article
- research article
- Published by Wiley in Psychiatry and Clinical Neurosciences
- Vol. 56 (3) , 273-274
- https://doi.org/10.1046/j.1440-1819.2002.00974.x
Abstract
It is reported that cerebrospinal fluid (CSF) hypocretin‐1 (orexin‐A) concentrations in patients with narcolepsy are significantly low. Human narcolepsy is also known to be closely associated with a specific human histocompatibility leukocyte antigen (HLA), suggesting that autoimmunity is involved in the pathophysiology of the disease. Thus, it is important to know whether hypocretin changes are found in definite neuroimmunological diseases such as multiple sclerosis and Guillain–Barré syndrome (GBS). The results of the present study indicate that some patients with GBS have lower levels of CSF hypocretin‐1.Keywords
This publication has 5 references indexed in Scilit:
- CSF hypocretin/orexin levels in narcolepsy and other neurological conditionsNeurology, 2001
- Low cerebrospinal fluid hypocretin (orexin) and altered energy homeostasis in human narcolepsyAnnals of Neurology, 2001
- Guillain - Barré syndromeCurrent Opinion in Neurology, 1999
- DQ (rather than DR) gene marks susceptibility to narcolepsyThe Lancet, 1992
- Mononucleosis and chronic daytime sleepiness. A long-term follow-up studyArchives of internal medicine (1960), 1986